| # | Drug | Count |
|---|---|---|
| 0 | VENLAFAXINE | 34 |
| 1 | VENLAFAXINE HYDROCHLORIDE | 34 |
| 2 | CYCLOBENZAPRINE | 31 |
| 3 | CLONAZEPAM | 27 |
| 4 | SIMVASTATIN | 26 |
| 5 | TEMAZEPAM | 26 |
| 6 | ZOLPIDEM TARTRATE | 26 |
| 7 | FLUOXETINE HYDROCHLORIDE | 25 |
| 8 | LORAZEPAM | 25 |
| 9 | FLUOXETINE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSPHENYTOIN SODIUM | 3 | 0.0012 |
| 1 | ISOFLURANE | 2 | 0.0010 |
| 2 | PENICILLIN V POTASSIUM | 2 | 0.0008 |
| 3 | TEMAZEPAM | 26 | 0.0007 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | 1 | 0.0007 |
| 5 | CYCLOBENZAPRINE | 31 | 0.0006 |
| 6 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 7 | GLYCOPYRROLATE | 3 | 0.0005 |
| 8 | FERUMOXYTOL | 1 | 0.0005 |
| 9 | FLIBANSERIN | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 38 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 27 |
| 2 | Opioid Agonist [EPC] | 20 |
| 3 | Corticosteroid [EPC] | 9 |
| 4 | Alkylating Drug [EPC] | 6 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 6 | Platinum-based Drug [EPC] | 5 |
| 7 | Atypical Antipsychotic [EPC] | 4 |
| 8 | Glycopeptide Antibacterial [EPC] | 4 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Contrast Agent for Ultrasound Imaging [EPC] | 2 | 0.0003 |
| 1 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 5 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 6 | Barbiturate [EPC] | 1 | 0.0001 |
| 7 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Opioid Agonist [EPC] | 20 | 0.0001 |
| 9 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |